The immunohistochemical analysis detected EIF3D expression in the ovarian adenoma, borderline lesion and cancer (serous cystadenocarcinoma, clear cell carcinoma and endometrial adenocarcinoma) tissues. This evidence concerns the gene EIF3D and endometrium adenocarcinoma.